*One enrolled participant was later found to not meet eligibility criteria and was subsequently discontinued from product use, one enrolled participant was erroneously thought to not meet eligibility
*All participants had been reported AFB+ by the field laboratory on ≥2 pre-enrolment sputum specimens. †The usual reason for vitD or vitD placebo to be withheld/deferred was hypercalcaemia.
